Third Point’s Loeb Seeks Second Head At Pharma
Aug 30 2007 | 11:45am ET
Apoplectic about PDL BioPharma’s proposed reorganization, New York activist hedge fund Third Point has reiterated its unhappiness with company management in no uncertain terms.
More News
- Olympia Launches Half-Index, Half-Fund Of Funds Product
- San Diego Pension Will Appeal Amaranth Ruling
- British Backed By Cyprus, Malta In Hedge Fund Fight
- Cohen Pays $110 Million For Famed Painting
- Man Chairman May Join ‘Red Knights’
- Family Offices Seek Hedge Fund Talent
- Barclays Vets To Launch Banking Hedge Fund In Spain
- Divine New Atlanta Hedge Fund Launches
- Elliott Out Of MGM Bidding
- Missouri Picks Three Hedge Funds, P.E. Shop For Mandates
- Saba Adds RenTech Marketer
- Hedge Fund Bets On Sex Toy Maker
- Church-Based Hedge Fund Fraudsters Plead Guilty
- Blackstone Plans $1 Billion Failed-Bank Fund
Q&A: Energy Expert Peter Fusaro Sees Lull In ‘Green’ Investing, Urges Patience
In Depth
Q&A: Energy Expert Peter Fusaro Sees Lull In ‘Green’ Investing, Urges Patience
Mar 19 2010 | 1:29pm ET
Two year ago cleantech, or green, investing was the strategy du jour....
Lifestyle
Cohen Pays $110 Million For Famed Painting
Mar 19 2010 | 9:50am ET
SAC Capital Advisors founder Steven Cohen has bought on of Jasper John’s famed...
Guest Contributor
Post-Crisis: Hedge Funds, Custodial Risk And Prime Brokers
Mar 16 2010 | 6:45am ET
Just a few years ago prime brokers viewed hedge funds as their main...
Upcoming Events
Most Popular
Service Providers
- Follow Us
- Send us News Tips!
2006-2010 FINalternatives is an information service of Stone Street Media, LLC.
